LBRX - LB Pharmaceuticals Inc Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
LB Pharmaceuticals Inc Common Stock
IPO Date: September 11, 2025
Sector: Healthcare
Industry: Biotechnology
Market Cap: $1.37B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.81 | 3.14%
Avg Daily Range (30 D): $1.13 | 2.42%
Avg Daily Range (90 D): $1.01 | 2.77%
Institutional Daily Volume
Avg Daily Volume: .22M
Avg Daily Volume (30 D): .23M
Avg Daily Volume (90 D): .24M
Trade Size
Avg Trade Size (Sh.): 60
Avg Trade Size (Sh.) (30 D): 46
Avg Trade Size (Sh.) (90 D): 51
Institutional Trades
Total Institutional Trades: 181
Avg Institutional Trade: $1.71M
Avg Institutional Trade (30 D): $1.89M
Avg Institutional Trade (90 D): $1.51M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.09M
Avg Closing Trade (30 D): $2M
Avg Closing Trade (90 D): $1.73M
Avg Closing Volume: 73.38K
 
News
Jul 22, 2026 @ 12:00 PM
LB Pharmaceuticals Announces Accelerated Timing of...
Source: Lb Pharmaceuticals Inc
Jul 10, 2026 @ 8:38 PM
LB Pharmaceuticals Reports Inducement Grant to New...
Source: Na
Feb 27, 2026 @ 4:44 PM
Psychedelic Biotechs Push Toward Phase 3: Five Com...
Source: Prnewswire
Feb 5, 2026 @ 1:00 PM
LB Pharmaceuticals Announces $100.0 Million Privat...
Source: Na
Jan 6, 2026 @ 12:00 PM
LB Pharmaceuticals Strengthens Leadership Team wit...
Source: Lb Pharmaceuticals, Inc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $.14 $-1.71 $-.67
Diluted EPS $.14 $-1.71 $-.67
Revenue
Gross Profit
Net Income / Loss $-85.69M $-51.6M $-19.05M
Operating Income / Loss
Cost of Revenue
Net Cash Flow $260.42M $-37.56M $70.51M
PE Ratio